French Biologist’s Marine Worm Innovation Heals Burns, Finalist for 2026 European Inventor Award
Franck Zal, a notable French biologist and former CNRS researcher, has made significant advancements in medical technology. He is the founder of Hemarina, a biotech firm located in Morlaix, France. His innovative work involves using a marine worm’s hemoglobin to create solutions that can heal burns and improve organ preservation.
Key Innovations for Medicine
Zal’s groundbreaking research enabled the development of a universal oxygen carrier. This carrier is derived from marine worm hemoglobin and is beneficial in medical applications. It helps preserve organs and tissues by providing essential oxygen during transport and storage. This technology has proven pivotal in enhancing transplant success rates.
Applications in Burn Treatment
One of Zal’s notable contributions is an innovative hydrogel product specifically designed for treating severe burns. This product has been utilized effectively in the aftermath of a tragic incident in Crans-Montana, Switzerland. Thousands of dressings have been dispatched to aid burn victims following a fire at a local bar in January 2026.
Recognition and Awards
Franck Zal has been recognized for his exceptional contributions to innovation. He has been selected as a finalist for the 2026 European Inventor Award, which acknowledges his work under the category of “SMEs.” The award ceremony will take place in Berlin on July 2, 2026.
Competition Overview
- Franck Zal (France) – Medical innovation with marine worm hemoglobin.
- Jan Čmelík (Czech Republic) – Needle-free electrospinning technology for mass production of nanofibers.
- Przemek Ben Paczek (Poland) – Magnetic levitation system aimed at modernizing rail networks.
The European Patent Office will announce the winners during a live event, and a public prize will also be awarded based on votes from the public combined with an independent jury’s assessment. Voting is open from May 12 to July 2, 2026.
